1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Letter regarding "Waiting for the changes after the adoption of steatotic liver disease".

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          A multisociety Delphi consensus statement on new fatty liver disease nomenclature

          The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This study set out to determine if content experts and patient advocates were in favor of a change in nomenclature and/or definition. A modified Delphi process was led by three large pan-national liver associations. The consensus was defined a priori as a supermajority (67%) vote. An independent committee of experts external to the nomenclature process made the final recommendation on the acronym and its diagnostic criteria. A total of 236 panelists from 56 countries participated in 4 online surveys and 2 hybrid meetings. Response rates across the 4 survey rounds were 87%, 83%, 83%, and 78%, respectively. Seventy-four percent of respondents felt that the current nomenclature was sufficiently flawed to consider a name change. The terms “nonalcoholic” and “fatty” were felt to be stigmatising by 61% and 66% of respondents, respectively. Steatotic liver disease was chosen as an overarching term to encompass the various aetiologies of steatosis. The term steatohepatitis was felt to be an important pathophysiological concept that should be retained. The name chosen to replace NAFLD was metabolic dysfunction–associated steatotic liver disease. There was consensus to change the definition to include the presence of at least 1 of 5 cardiometabolic risk factors. Those with no metabolic parameters and no known cause were deemed to have cryptogenic steatotic liver disease. A new category, outside pure metabolic dysfunction–associated steatotic liver disease, termed metabolic and alcohol related/associated liver disease (MetALD), was selected to describe those with metabolic dysfunction–associated steatotic liver disease, who consume greater amounts of alcohol per week (140–350 g/wk and 210–420 g/wk for females and males, respectively). The new nomenclature and diagnostic criteria are widely supported and nonstigmatising, and can improve awareness and patient identification.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Can we use old NAFLD data under the new MASLD definition?

                Bookmark

                Author and article information

                Journal
                Clin Mol Hepatol
                Clinical and molecular hepatology
                The Korean Association for the Study of the Liver
                2287-285X
                2287-2728
                Jan 2024
                : 30
                : 1
                Affiliations
                [1 ] Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, Singapore.
                [2 ] Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
                [3 ] Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.
                [4 ] State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.
                [5 ] National Skin Centre and Skin Research Institute of Singapore (SRIS), Singapore.
                Article
                cmh.2023.0472
                10.3350/cmh.2023.0472
                10776288
                37957811
                6a147d8c-1f90-4e72-8149-47bf350fcfcc
                History

                Alcohol,Social policies,NAFLD,Metabolic,Fatty liver
                Alcohol, Social policies, NAFLD, Metabolic, Fatty liver

                Comments

                Comment on this article